Annual Conference

ASBH22 ConfBan 1242x170

Plenary Sessions*

Reframing the Great Resignation in Healthcare 

Thursday, October 27, 11:15 am–12:30 pmMary Ersek, PhD RN FPCN; Pringl Miller, MD FACS; Mara Buchbinder, PhD, Moderator 

We have all heard that high numbers of healthcare workers have chosen to leave their jobs during the COVID-19 pandemic. Terms like “Great Resignation” put the focus on the individual who decides to leave, rather than the environment. This panel will focus on the structural issues that have contributed to the departure of healthcare workers, such as racism, sexism, ableism, and other forms of bias and systemic disadvantage that adversely impact healthcare workers, which pre-date the pandemic. Our panelists will offer their perspectives and wisdom on these larger problems and address the role of bioethics and the humanities in thinking about and helping to solve them.    

Reclaiming Indigenous Public Health: Decolonizing Data and Racial Disparities 

Friday, October 28, 11:15 am–12:30 pmAbigail Echo-Hawk, MA  

At the height of the pandemic, Abigail Echo-Hawk and the Seattle Indian Health Board requested additional personal protective equipment for Washington’s Indigenous communities. They received body bags instead. Join Echo-Hawk for a discussion of this experience and other ways that racism and resource allocation lead to public health disparities for Indigenous communities, with implications for policy, clinical care, and research. 

Doing Bioethics in Public: A Conversation About the Aducanumab Controversy 

Saturday, October 29, 3:15 pm–4:30 pmJason Karlawish, MD; Holly Fernandez Lynch, JD MBE  

In June 2021, the FDA approved Biogen’s aducanumab for the treatment of Alzheimer’s disease–and with that, patients and their caregivers finally had a treatment. Or did they? In the months that followed, controversy unfolded over several domains: regulatory capture at the FDA, the difficult balance between speed and certainty, the role of advocacy groups and patient desperation, the relevance of expertise, the distortion of innovation, the cost and coverage of drugs, and more. Join Holly Fernandez Lynch and Jason Karlawish for a conversation about their experiences wading into this controversy and doing bioethics in public.

*All times listed are Pacific Daylight Time (PDT).